RecruitingNCT05438511

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

85 participants

Start Date

Apr 13, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.


Eligibility

Min Age: 18 Years

Inclusion Criteria11

  • Breast cancer survivor, patient advocate or key healthcare personnel
  • Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with:
  • \>12 months of employment at the affiliated institution
  • Administrative or clinical involvement in the delivery of breast cancer care services.
  • Age 18 years and above
  • Permanent residents or citizens of Tanzania
  • Participant and/or LAR willing and able to consent
  • Fluent in Swahili and/or English by self-report
  • Age 18 years and above
  • Permanent residents or citizens of Tanzania
  • Received breast cancer diagnosis

Exclusion Criteria3

  • Key stakeholder not residing at their particular institutions during data collection will be excluded.
  • Eligibility criteria for Chart Reviews (Aim 1)
  • Participants less than 18 years of age

Interventions

BEHAVIORALFocus group

A semi-structured focus group discussion guide will be developed with question probes that cover 1) contextual factors, 2) barriers to implementation, and 3) facilitators to implementation, with secondary probing questions.

BEHAVIORALOrganizational Readiness for Implementing Change

measures the extent to which organizational members are prepared to implement organizational change. The ORIC tool asks participants to rate their level of agreement with 12 statements pertaining to organizational readiness for change (change commitment and change efficacy) on a 5-point Likert Scale.


Locations(2)

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States

Muhimbili University of Health and Allied Sciences

Dar es Salaam, Tanzania

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05438511


Related Trials